Year-End Message from NORD’s President and CEO
For more than 35 years, NORD has been the voice of the rare disease community. Whether it’s advocating in Washington, protecting the Orphan Drug Act, working with the FDA to …
Continue reading “Year-End Message from NORD’s President and CEO”
Read more